TR-644 a novel potent tubulin binding agent induces impairment of endothelial cells function and inhibits angiogenesis.
about
The Novel Antitubulin Agent TR-764 Strongly Reduces Tumor Vasculature and Inhibits HIF-1α Activation.Current Advances of Tubulin Inhibitors in Nanoparticle Drug Delivery and Vascular Disruption/AngiogenesisSynthesis and Biological Evaluation of 2-Methyl-4,5-Disubstituted Oxazoles as a Novel Class of Highly Potent Antitubulin Agents.Synthesis, antimitotic and antivascular activity of 1-(3',4',5'-trimethoxybenzoyl)-3-arylamino-5-amino-1,2,4-triazoles.Design, synthesis, in vitro, and in vivo anticancer and antiangiogenic activity of novel 3-arylaminobenzofuran derivatives targeting the colchicine site on tubulin.AECHL-1, a novel triterpenoid, targets tumor neo-vasculature and impairs the endothelial cell cytoskeleton.Novel Etoposide Analogue Modulates Expression of Angiogenesis Associated microRNAs and Regulates Cell Proliferation by Targeting STAT3 in Breast Cancer.Novel 3-Substituted 7-Phenylpyrrolo[3,2-f]quinolin-9(6H)-ones as Single Entities with Multitarget Antiproliferative ActivityDesign, synthesis, crystallization and biological evaluation of new symmetrical biscationic compounds as selective inhibitors of human Choline Kinase α1 (ChoKα1)ZLM-7 exhibits anti-angiogenic effects via impaired endothelial cell function and blockade of VEGF/VEGFR-2 signaling.Concise synthesis and biological evaluation of 2-Aroyl-5-amino benzo[b]thiophene derivatives as a novel class of potent antimitotic agents.Recent advances in vascular disrupting agents in cancer therapy.New more polar symmetrical bipyridinic compounds: new strategy for the inhibition of choline kinase α1.Desacetylvinblastine Monohydrazide Disrupts Tumor Vessels by Promoting VE-cadherin Internalization.
P2860
Q27341833-842ED263-0059-48D5-82A9-DDB366F56036Q28077780-780F197F-78A6-4DA4-871A-C0B3628D4E50Q33560133-8800BCC5-CB33-4958-84FA-B6577406365FQ34155028-B8CD0FAA-73B6-4B28-9A86-D89D464B8A9AQ35532093-1D3C37A7-2381-4CFB-9D5B-199C8B38C814Q35757079-DAB14C0B-C6C7-41DA-8B51-E3140E4CC3C4Q35835942-34E1C2D7-7532-43AA-B710-69B912440553Q36239589-51B9124B-BBFF-4338-9687-C04C6238EA87Q36748138-6DDB7772-7275-4425-9527-B23AB033938DQ37109919-C53DE11D-AE5A-49FD-9CAD-FDB6EE90BD41Q37507733-0A27AB22-5FF4-45C0-8E0A-86913CDF1D37Q38264533-6604CA89-3257-4A53-8D5D-BE0D36A2A353Q39017908-D57C9778-E176-45CF-A90C-3F1DD5AC10CEQ47139353-BA2C25D7-878A-438A-9297-FCF8354872BD
P2860
TR-644 a novel potent tubulin binding agent induces impairment of endothelial cells function and inhibits angiogenesis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
TR-644 a novel potent tubulin ...... ion and inhibits angiogenesis.
@en
TR-644 a novel potent tubulin ...... ion and inhibits angiogenesis.
@nl
type
label
TR-644 a novel potent tubulin ...... ion and inhibits angiogenesis.
@en
TR-644 a novel potent tubulin ...... ion and inhibits angiogenesis.
@nl
prefLabel
TR-644 a novel potent tubulin ...... ion and inhibits angiogenesis.
@en
TR-644 a novel potent tubulin ...... ion and inhibits angiogenesis.
@nl
P2093
P2860
P1433
P1476
TR-644 a novel potent tubulin ...... ion and inhibits angiogenesis.
@en
P2093
Elena Porcù
Giuseppe Basso
Marco Presta
Pier Giovanni Baraldi
Roberta Bortolozzi
Roberto Ronca
Romeo Romagnoli
Stefania Mitola
P2860
P2888
P304
P356
10.1007/S10456-013-9343-Z
P577
2013-03-02T00:00:00Z